On November 28, 1520, Portuguese navigator Ferdinand Magellan reached the Pacific Ocean after passing through the South American strait that now bears his name.

InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a ...

IBN ? Annovis Bio Inc. ("Annovis" or the "Company"), a late-stage clinical drug platform company developing transformative ...

Utilising genetic information responsibly allows people to understand the uncertain waters of Alzheimer's with both knowledge and hope; ready to confront challenges together. Here’s why genetic testin ...

This study highlights the efficacy of home-based tDCS in treating major depressive disorder, with significant improvements in ...

Listen to episode nine, “Executing Clinical Research in Dementia with Lewy Bodies (DLB)” on the Conversations tab of the Cognition website. This conversation is presented in 3 Chapters: 1) Comparing ...

Late-breaking oral presentation to highlight safety and efficacy of LX1001 across four dose cohorts NEW YORK, Oct. 22, 2024 ...

Within Tibetan medicine, the medicinal herb Terminalia chebula (T. chebula) is well-known for its extensive therapeutic ...

Dementia is a syndrome linked to the ongoing decline of the brain and can be hard to spot in its early stages. With the ...

New research has revealed that a class of proteins possesses a previously unknown cell-protecting function that could be ...

Health Alzheimer's Disease study plans to study 2,000 volunteers' brain scans and blood work to identify biomarkers of ...

In the supplementary post-hoc analysis, treatment with solengepras 150 mg group reduced OFF time by -1.78 hours (p= 0.0045) compared to placebo and increased good ON time by +1.3 hours (p=0.04).